Jarbas Caiado de Castro
Directeur Général chez Opto Eletrônica SA
Profil
Jarbas Caiado de Castro is the founder of Opto Global Pty Ltd.
which was founded in 2003.
He is currently the President & Chief Executive Officer at Opto Eletrônica SA. Mr. de Castro obtained a doctorate degree from the Massachusetts Institute of Technology in 1981.
He also holds undergraduate and graduate degrees from the University of Sao Paulo.
Postes actifs de Jarbas Caiado de Castro
| Sociétés | Poste | Début |
|---|---|---|
Opto Eletrônica SA
 Opto Eletrônica SA Medical SpecialtiesHealth Technology Opto Eletrônica SA manufactures medical-ophthalmic products. It serves medical, aerospace, industrial and end-consumer sectors. The firm's products include anti-glare lenses, satellite cameras, surgical lasers and measuring instruments. The company was founded in 1985 and is headquartered in São Carlos, Brazil. | Directeur Général | 01/01/1988 |
Anciens postes connus de Jarbas Caiado de Castro
| Sociétés | Poste | Fin |
|---|---|---|
Opto Global Pty Ltd.
 Opto Global Pty Ltd. Medical SpecialtiesHealth Technology Opto Global is a privately owned company focused on sales, marketing and development of ophthalmic equipment. The company is based in Adelaide, South, from where it distributes its products to over 60 countries through local independent distributors. The company's vision is to deliver superior returns to shareholders through a focus on sales and development of ophthalmic products to the global market. Opto Global is committed to development and commercialisation of new technologies for the treatment and diagnosis of diseases of the eye resulting in cutting edge products for ophthalmologists, optometrists, hospitals and associated health care professionals. Opto Global was incorporated in April 2003 and is building on its profitable foundations to deliver new market leading products. Some of the most recent product innovations include the Opto AP200 Automated Perimeter, the world's first solid state blue on yellow automated perimeter for the early diagnosis of glaucoma; the Opto i-MP (Indocyanine green Mediated Photothrombosis) which is progressing through clinical trials with the intention of treating a significant amount of people with Age-related Macular Degeneration (AMD); and, Opto Global is developing an innovative device to assist in cataract surgery which has become the most frequent ophthalmic surgical procedure around the world. | Fondateur | - |
Formation de Jarbas Caiado de Castro
| Massachusetts Institute of Technology | Doctorate Degree |
| University of Sao Paulo | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Opto Eletrônica SA
Opto Eletrônica SA Medical SpecialtiesHealth Technology Opto Eletrônica SA manufactures medical-ophthalmic products. It serves medical, aerospace, industrial and end-consumer sectors. The firm's products include anti-glare lenses, satellite cameras, surgical lasers and measuring instruments. The company was founded in 1985 and is headquartered in São Carlos, Brazil. | Health Technology |
Opto Global Pty Ltd.
Opto Global Pty Ltd. Medical SpecialtiesHealth Technology Opto Global is a privately owned company focused on sales, marketing and development of ophthalmic equipment. The company is based in Adelaide, South, from where it distributes its products to over 60 countries through local independent distributors. The company's vision is to deliver superior returns to shareholders through a focus on sales and development of ophthalmic products to the global market. Opto Global is committed to development and commercialisation of new technologies for the treatment and diagnosis of diseases of the eye resulting in cutting edge products for ophthalmologists, optometrists, hospitals and associated health care professionals. Opto Global was incorporated in April 2003 and is building on its profitable foundations to deliver new market leading products. Some of the most recent product innovations include the Opto AP200 Automated Perimeter, the world's first solid state blue on yellow automated perimeter for the early diagnosis of glaucoma; the Opto i-MP (Indocyanine green Mediated Photothrombosis) which is progressing through clinical trials with the intention of treating a significant amount of people with Age-related Macular Degeneration (AMD); and, Opto Global is developing an innovative device to assist in cataract surgery which has become the most frequent ophthalmic surgical procedure around the world. | Health Technology |